Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Key Points

• Kestra Medical Technologies, Ltd. has an average rating of "Moderate Buy" from six brokerages, with one hold rating and five buy ratings among its analysts.
• The average price target for the stock is $27.33, although Goldman Sachs and Wells Fargo have recently downgraded their estimates to $23.00 and $27.00 respectively.
• Shares of Kestra Medical Technologies opened at $15.38, with a twelve-month price range between $13.25 and $26.15.

Shares of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the six research firms that are presently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $27.3333.

KMTS has been the topic of a number of research reports. Wells Fargo & Company reduced their target price on shares of Kestra Medical Technologies from $28.00 to $27.00 and set an "overweight" rating on the stock in a report on Thursday, July 17th. The Goldman Sachs Group reduced their price objective on Kestra Medical Technologies from $24.00 to $23.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 16th.

Institutional Investors Weigh In On Kestra Medical Technologies

Large investors have recently made changes to their positions in the stock. Quarry LP purchased a new stake in shares of Kestra Medical Technologies in the 1st quarter valued at $33,000. Virtu Financial LLC acquired a new stake in Kestra Medical Technologies during the 1st quarter worth about $210,000. Armistice Capital LLC acquired a new position in shares of Kestra Medical Technologies in the 1st quarter valued at about $312,000. Zimmer Partners LP acquired a new stake in Kestra Medical Technologies during the first quarter worth about $374,000. Finally, Russell Investments Group Ltd. purchased a new position in Kestra Medical Technologies during the first quarter valued at approximately $457,000.

Kestra Medical Technologies Stock Up 2.4%

Shares of KMTS traded up $0.37 during mid-day trading on Friday, hitting $15.86. 241,241 shares of the stock were exchanged, compared to its average volume of 419,172. The stock has a 50-day simple moving average of $17.25. Kestra Medical Technologies has a 52-week low of $13.25 and a 52-week high of $26.15. The company has a debt-to-equity ratio of 0.20, a current ratio of 6.72 and a quick ratio of 6.72.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.